Chronic Chlamydia pneumoniae infection in patients with symptomatic atherothrombosis

Journal of Infection

Volumn 53, Issue 2, 2006, Pages 93-97

  Halfon, P ^a   Limal, N ^b   Penaranda, G ^c   Khiri, H ^a   Sene, D ^b   Andreu, M ^b   Feryn, J M ^a   Rotily, M ^d   Serra, R ^d   Piette, J C ^b   Cacoub, P ^b  

^a Laboratoire Alphabio   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CDL Pharma   (France)

^d Clinsearch ^*  (France)

Author keywords

Anti chlamydia treatment; Atherothrombosis; Cardiovascular risk; Chlamydia pneumoniae

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPID;

ADULT; AGE; ANTIBODY TITER; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; LEG ISCHEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SCREENING; SMOKING; SYMPTOM;

ADULT; AGED; ANTIBODIES, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; COHORT STUDIES; EMBOLISM, CHOLESTEROL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE;

EID: 33746016347     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.10.027     Document Type: Article

References (27)

1. Wood D. Established and emerging cardiovascular risk factors. Am Heart J 141 2 Suppl. (2001) S49-S57
2. Siscovick D.S., Schwartz S.M., Caps M., Wang S.P., and Grayston J.T. Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. J Infect Dis 181 Suppl. 3 (2000) S417-S420
3. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 8618 (1988) 983-986
4. Grayston J.T., Kuo C.C., Coulson A.S., Campbell L.A., Lawrence R.D., Lee M.J., et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92 12 (1995) 3397-3400
5. LaBiche R., Koziol D., Quinn T.C., Gaydos C., Azhar S., Ketron G., et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32 4 (2001) 855-860
6. Saikku P. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 138 5 Pt 2 (1999) S500-S503
7. Grayston J.T. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181 Suppl. 3 (2000) S402-S410
8. Hermann C., Gueinzius K., Oehme A., Von Aulock S., Straube E., and Hartung T. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 42 6 (2004) 2476-2479
9. Persson K., and Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol 7 (2000) 739-744
10. Krausse R., Leiendecker J., Herrmann G., Harder T., and Ullmann U. Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease. Infection 31 (2003) 149-154
11. Kawamoto R., Doi T., Tokunaga H., and Konishi I. An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis. Intern Med 40 (2001) 208-213
12. Wolf S.C., Mayer O., Jurgens S., Vonthein R., Schultze G., Risler T., et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 59 (2003) 273-279
13. Song H., Tasaki H., Yashiro A., Okasaki M., Ioka T., Taniguchi H., et al. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Clin Nephrol 56 (2001) 346-352
14. Khairy P., Rinfret S., Tardif J.C., Marchand R., Shapiro S., Brophy J., et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation 107 (2003) 1966-1971
15. Shimizu C., Nabeshima S., Kikuchi K., Furusyo N., Kashiwagi S., and Hayashi J. Prevalence of antibody to Chlamydia pneumoniae in residents of Japan, the Solomon Islands, and Nepal. Am J Trop Med Hyg 67 (2002) 170-175
16. O'Neill C., Murray L.J., Ong G.M., O'Reilly D.P., Evans A.E., and Bamford K.B. Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country. Epidemiol Infect 122 1 (1999) 111-116
17. Gaydos C.A., Summersgill J.T., Shane N.N., Ramireze J.A., and Quinn T.C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64 (1996) 1614-1620
18. Schumacher A., Lerkerød A.B., Seljeflot I., Sommervoll L., Holme I., Otterstad J.E., et al. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 39 (2001) 1859-1864
19. Hoymans V.Y., Bosmans J.M., Van Renterghem L., Mak R., Ursi D., Wuyts F., et al. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis. J Clin Microbiol 41 (2003) 4049-4053
20. Markus H.S., Sitzer D.M., Carrington D., Mendall M.A., and Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 100 (1999) 832-837
21. Huo C.C., Jackson L.A., Campbell L.A., and Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8 (1995) 451-461
22. Elkind M., Lyn I., Grayston J., and Sacco R. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 31 (2000) 1521-1525
23. Cook P.J., Honeybourne D., Lip G.Y.H., Beevers D.G., Wise R., and Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 29 (1998) 404-410
24. Wells B.J., Mainous III A.G., and Dickerson L.M. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials. Arch Intern Med 164 19 (2004 Oct 25) 2156-2161
25. Kardara M., Papazafiropoulou A., Katsakiori P., Petropoulos C., and Jelastopulu E. Protective effect of doxycycline use on coronary artery disease?. J Infect (2005) [Epub ahead of print]
26. Kutlin A., Roblin P.M., and Hammerschlag M.R. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. J Antimicrob Chemother 49 (2002) 763-767
27. Kutlin A., Roblin P.M., and Hammerschlag M.R. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model. Antimicrob Agents Chemother 46 (2002) 409-412